Skip to main content
Clinical Trials/ACTRN12620001192976
ACTRN12620001192976
Not yet recruiting
未知

Pulmonary function measured by spirometry in patients with acute rib fractures treated with either paravertebral blockade or erector spinae plane block: A pilot study

Middlemore Hospital0 sites40 target enrollmentNovember 10, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Middlemore Hospital
Enrollment
40
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 10, 2020
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Middlemore Hospital

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria:
  • \-Adult patients aged greater than 18 years old
  • \-Three or more rib fractures diagnosed on either plain radiograph or computed tomography (CT) scan of the chest
  • \-Decision by the Pain Service to insert a continuous regional analgesic catheter – defined as either:
  • oParavertebral catheter
  • oErector spinae plane catheter
  • \-American Society of Anaesthesiologists Physiologic State (ASA\-PS) classification of I\-IV

Exclusion Criteria

  • Exclusion Criteria:
  • \-Patients who are unable or unwilling to offer verbal and / or written informed consent, either in person or through their proxy including those with limitations in communication where interpretation is unavailable
  • \-Sternal or bilateral rib fractures
  • \-Pre\-existing spinal deformity which precludes the insertion of a continuous regional analgesic catheter
  • \-Local infection or trauma at proposed site of injection
  • \-Known allergy to the local anaesthetic agents (ropivacaine and bupivacaine) used in the study.
  • \-Those with significant trauma outside the chest wall e.g., acute spinal fractures with or without spinal cord injury; significant pelvic or long bone fractures, severe traumatic brain injury, or abdominal visceral injuries
  • \-Patients on anticoagulants or anti\-platelets except Aspirin

Outcomes

Primary Outcomes

Not specified

Similar Trials